Search Results - Cesar A. Santa‐Maria

Refine Results
  1. 1
    Immune Checkpoint Inhibitor Therapy in Breast Cancer

    Immune Checkpoint Inhibitor Therapy in Breast Cancer by Cesar A. Santa‐Maria, Rita Nanda

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer

    Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer by Hanwen Wang, Chen Zhao, Cesar A. Santa‐Maria, Leisha A. Emens, Aleksander S. Popel

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition

    A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition by Theinmozhi Arulraj, Hanwen Wang, Leisha A. Emens, Cesar A. Santa‐Maria, Aleksander S. Popel

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    <i>In silico</i> simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model

    <i>In silico</i> simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model by Hanwen Wang, Oleg Milberg, Imke H. Bartelink, Paolo Vicini, Bing Wang, Rajesh Narwal, Lorin Roskos, Cesar A. Santa‐Maria, Aleksander S. Popel

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    PTEN, PIK3CA, p-AKT, and p-p70S6K Status

    PTEN, PIK3CA, p-AKT, and p-p70S6K Status by Francisco J. Esteva, Hua Guo, Siyuan Zhang, Cesar A. Santa‐Maria, Steven Stone, Jerry S. Lanchbury, Ayşegül A. Şahin, Gabriel N. Hortobágyi, Dihua Yu

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer

    Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer by Eric Xie, Maya M. Lapinski, Sarah Talamantes, Bareng A. S. Nonyane, Maria Cristina Figueroa Magalhães, Kala Visvanathan, Antonio C. Wolff, Cesar A. Santa‐Maria

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer

    Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer by Ami N. Shah, Lisa Flaum, Irene Helenowski, Cesar A. Santa‐Maria, Sarika Jain, Alfred Rademaker, Valerie Nelson, Dean Tsarwhas, Massimo Cristofanilli, William J. Gradishar

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Genomic landscape of DNA repair genes in cancer

    Genomic landscape of DNA repair genes in cancer by Young Kwang Chae, Jonathan F. Anker, Benedito A. Carneiro, Sunandana Chandra, Jason Kaplan, Aparna Kalyan, Cesar A. Santa‐Maria, Leonidas C. Platanias, Francis J. Giles

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives

    Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives by Ricardo Costa, Benedito A. Carneiro, Derek A. Wainwright, Cesar A. Santa‐Maria, Priya Kumthekar, Young Kwang Chae, William J. Gradishar, Massimo Cristofanilli, Francis J. Giles

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer

    Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer by Young Kwang Chae, Andrew A. Davis, Sarika Jain, Cesar A. Santa‐Maria, Lisa Flaum, Nike Beaubier, Leonidas C. Platanias, William J. Gradishar, Francis J. Giles, Massimo Cristofanilli

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy

    Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy by Abenaa M. Brewster, Gabriel N. Hortobágyi, Kristine Broglio, Shu‐Wan Kau, Cesar A. Santa‐Maria, Banu K. Arun, Aman U. Buzdar, Daniel J. Booser, V. Valero, Melissa L. Bondy, Francisco J. Esteva

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate

    Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate by Preethi Korangath, Wei Wen Teo, Helen Sadik, Liangfeng Han, Noriko Mori, Charlotte M. Huijts, Flonné Wildes, Santosh Kumar Bharti, Zhe Zhang, Cesar A. Santa‐Maria, Hua‐Ling Tsai, Chi V. Dang, Vered Stearns, Zaver M. Bhujwalla, Saraswati Sukumar

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer

    Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer by Brian D. Lehmann, Vandana G. Abramson, Elizabeth Claire Dees, Payal D. Shah, Tarah J. Ballinger, Claudine Isaacs, Cesar A. Santa‐Maria, Hanbing An, Paula I. González-Ericsson, Melinda E. Sanders, Kimberly C. Newsom, Richard G. Abramson, Quanhu Sheng, Chih–Yuan Hsu, Yu Shyr, Antonio C. Wolff, Jennifer A. Pietenpol

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach

    Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach by Jennifer Y. Sheng, Cesar A. Santa‐Maria, Neha Mangini, Haval Norman, Rima Couzi, Raquel Nunes, Mary Wilkinson, Kala Visvanathan, Roisín M. Connolly, Evanthia T. Roussos Torres, John H. Fetting, Deborah K. Armstrong, Jessica Tao, Lisa K. Jacobs, Jean L. Wright, Elissa Thorner, Christine Hodgdon, Samantha R. Horn, Antonio C. Wolff, Vered Stearns, Karen L. Smith

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers

    Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers by Jarushka Naidoo, Karisa C. Schreck, Wei Fu, Chen Hu, Alexander Carvajal-González, Roisín M. Connolly, Cesar A. Santa‐Maria, Evan J. Lipson, Matthias Holdhoff, Patrick M. Forde, Christopher Douville, Joanne Riemer, Amanda Barnes, Kristin J. Redmond, Lawrence Kleinberg, B.R. Page, Nafi Aygün, Kenneth W. Kinzler, Nickolas Papadopoulos, Chetan Bettegowda, Arun Venkatesan, Julie R. Brahmer, Stuart A. Grossman

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer by Brandie C. Taylor, Xiaopeng Sun, Paula I. González-Ericsson, Violeta Sánchez, Melinda E. Sanders, Elizabeth C. Wescott, Susan R. Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry Gómez, Claudine Isaacs, Tarah J. Ballinger, Cesar A. Santa‐Maria, Payal D. Shah, Elizabeth Claire Dees, Brian D. Lehmann, Vandana G. Abramson, Jennifer A. Pietenpol, Justin M. Balko

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

    A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013 by Foluso O. Ademuyiwa, Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski, Mili Arora, Adam Brufsky, Elizabeth Claire Dees, Cesar A. Santa‐Maria, Roisín M. Connolly, Jeremy Force, Alvaro Moreno‐Aspitia, John M. Herndon, Madelyn Carmody, Sherri R. Davies, Sarah Larson, Kathleen L. Pfaff, Stephanie Jones, Jason L. Weirather, Anita Giobbie‐Hurder, Scott J. Rodig, Zheng Liu, Ian S. Hagemann, Elad Sharon, William E. Gillanders

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

    TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes by Nadine Tung, Mark E. Robson, Steffen Ventz, Cesar A. Santa‐Maria, Rita Nanda, P. Kelly Marcom, Payal D. Shah, Tarah J. Ballinger, Eddy S. Yang, Shaveta Vinayak, Michelle Melisko, Adam Brufsky, Michelle K. DeMeo, C. David Jenkins, Susan M. Domchek, Alan D. D’Andrea, Nancy U. Lin, Melissa E. Hughes, Lisa A. Carey, Nick Wagle, Gerburg M. Wulf, Ian E. Krop, Antonio C. Wolff, Eric P. Winer, Judy E. Garber

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial

    The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial by Jason J. Luke, Manish R. Patel, George R. Blumenschein, Erika Hamilton, Bartosz Chmielowski, Susanna V. Ulahannan, Roisín M. Connolly, Cesar A. Santa‐Maria, Jie Wang, Shakeela Bahadur, Andrew Weickhardt, Adam S. Asch, Girish Mallesara, Philip R. Clingan, Monika Długosz‐Danecka, Monika Tomaszewska‐Kiecana, Halyna Pylypenko, Nada Hamad, Hedy L. Kindler, Bradley Sumrow, Patrick Kaminker, Francine Z. Chen, Xiaoyu Zhang, Kalpana Shah, Douglas H. Smith, Anushka De Costa, Jonathan Li, Hua Li, Jichao Sun, Paul A. Moore

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022

    Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast C... by Rachel A. Freedman, Hillary Heiling, T. Li, Dario Trapani, Nabihah Tayob, Karen L. Smith, Robert Davis, Alyssa Pereslete, M.K. DeMeo, Caitlin Cotter, W. Y. Chen, Heather A. Parsons, Cesar A. Santa‐Maria, Catherine Van Poznak, Beverly Moy, Adam Brufsky, M.E. Melisko, Ciara C. O’Sullivan, Nadia Ashai, Yasmeen Rauf, J.R. Nangia, Robert T. Burns, J. Savoie, Antonio C. Wolff, E.P. Winer, M.F. Rimawi, I.E. Krop, N.U. Lin

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: